News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Novel SERD shows promise for ER+/HER2– advanced/metastatic breast cancer
30 Dec 2021
byAudrey Abella
The novel oral SERD* elacestrant demonstrated potential as new treatment alternative for ER+/HER2– advanced/metastatic breast cancer (mBC) following progression on prior endocrine and CDK4/6 inhibitor therapy, according to the phase III EMERALD trial.
30 Dec 2021

Early mortality high among multiple myeloma patients
30 Dec 2021
Though decreasing over time, early mortality remains high in patients with multiple myeloma (MM), a recent study has found. Important risk factors include older age, a more aggressive disease, and a patient’s poor physical condition.
30 Dec 2021






